Cannabis company Pyxus International Inc. (PYX) - Get Report  was losing some of its newly acquired luster Wednesday, Oct. 10, as the stock dropped double digits following a steep run-up the previous two sessions.

Shares of Pyxus were down 11.5% to $35.51 on Wednesday after jumping about 50% to nearly $52 this week. 

The jump came after short-seller Andrew Left's Citron Research published a bullish note on the company.

Meanwhile, fellow pot company DAVIDsTEA Inc. (DTEA) - Get Report  was down more than 7%, giving back some of the gains it made earlier this week when it was up as much as 20%. 

Start, and end, your trading day right with TheStreet's 'Daily Snapshot' on your favorite smart-speaker. Learn more about TheStreet's market coverage for your trusted smart-speaker here.

Tilray Inc. (TLRY) - Get Report , Wall Street's current cannabis stock of choice, was showing tepid gains of less than 0.1% after two straight sessions of declines. For the week, Tilray is down more than 8%. 

Want to Buy $1 Worth of Stock for 90 Cents or Less?Click here to register for a free online video in which TheStreet's retirement expert Robert Powell and an all-star panel. The webinar is sponsored by Nuveen.

To be a profitable investor and build long-term wealth, you need the right information and techniques. Join TheStreet Oct. 13, 2018 for a special investing event for sophisticated and active traders. Register for "Invest Like the Pros: Jim Cramer's Boot Camp for Investors" here.

Image placeholder title